ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS

艾滋病毒/艾滋病青少年药物试验网络

基本信息

  • 批准号:
    6331772
  • 负责人:
  • 金额:
    $ 151.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-04-16 至 2006-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant): The University of Maryland STAR TRACK Adolescent HIV Program (STAR TRACK Program) is a clinical and research unit with significant experience in the areas of adolescent HIV research. STAR TRACK is the only adolescent exclusive HIV service in the state of Maryland and has a comprehensive "one stop shopping" model of care, a state wide community outreach program, an HIV early identification program through an adolescent specific HIV counseling and testing unit, and a Youth Care Network that serves as referral network for both HIV+ and HIV-youths. Our program has been one of 15 sites of the Adolescent HIV/AIDS Research Network since 1994 with a successful track record of recruitment, retention, site performance, quality assurance. Our PI, study coordinators, and Youth Community Advisory Board member have productively participated in and contributed towards the AMHARN mission and its goals. Our program has extensive experience in the recruitment and retention of HIV+ and HIV-adolescents in clinical care and research, and an active caseload of 105 HIV+ youths (many of whom have research experience) and 125 HIV-youths. STAR TRACK has strong clinical and research collaborations with other clinical sites for a total of 180 HIV infected young people under the age of 24. Our program has highly experienced adolescent researchers and study coordinators as well as basic and clinical researchers of the Division of Pediatric Immunology and the Institute of Human Virology of the University of Maryland. These investigators have an extensive track record of leadership in multicenter collaborative trials. The tight interface between community outreach, early identification of HIV, linkage to care and research, and comprehensive primary and subspecialty care, intrinsic to STAR TRACK?s structure, facilitates the major goals of the ATN. These relationships also provide a great structure to expand subject recruitment. This application details the current clinical and research capacity of the Adolescent Medicine Trial Unit (AMTU) to conduct research protocols related to the primary, secondary and tertiary prevention of HIV. High-risk populations available for this research include high-risk sexual minority and heterosexual youths, as well as incarcerated and substance abusing youths. In addition, it includes youths in transitional housing situation and school dropouts. Furthermore, the strong collaboration with an experienced laboratory, database manager and other University of Maryland scientists with expertise in HIV clinical trials and vaccine development provides an optimal environment for enriching the basic science and laboratory-based agenda of the ATN.
描述:(由申请人提供):马里兰大学STAR TRACK

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ligia Peralta其他文献

Ligia Peralta的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ligia Peralta', 18)}}的其他基金

Clinical Core
临床核心
  • 批准号:
    7762449
  • 财政年份:
    2009
  • 资助金额:
    $ 151.22万
  • 项目类别:
ATN 021B: PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV-INFEC
ATN 021B:HIV 感染者形态和代谢异常的患病率
  • 批准号:
    7608165
  • 财政年份:
    2007
  • 资助金额:
    $ 151.22万
  • 项目类别:
ATN 004: HEALTHY CHOICES: MOTIVATIONAL ENHANCEMENT TO PROMOTE HEALTH AND REDU
ATN 004:健康选择:增强动机以促进健康和减少疾病
  • 批准号:
    7608149
  • 财政年份:
    2007
  • 资助金额:
    $ 151.22万
  • 项目类别:
ATN 021: PREVALENCE OF MORPHOLOGIC AND METABOLIC ABNORMALITIES
ATN 021:形态和代谢异常的患病率
  • 批准号:
    7376938
  • 财政年份:
    2006
  • 资助金额:
    $ 151.22万
  • 项目类别:
ATN 004: HEALTHY CHOICES
ATN 004:健康的选择
  • 批准号:
    7376968
  • 财政年份:
    2006
  • 资助金额:
    $ 151.22万
  • 项目类别:
ATN 021 METABOLIC ABNORMALITIES
ATN 021 代谢异常
  • 批准号:
    7203309
  • 财政年份:
    2005
  • 资助金额:
    $ 151.22万
  • 项目类别:
Adolescent Trials Network for HIV/AIDS Interventions
青少年艾滋病毒/艾滋病干预试验网络
  • 批准号:
    7050726
  • 财政年份:
    2001
  • 资助金额:
    $ 151.22万
  • 项目类别:
ADOLESCENT TRIAL NETWORK FOR HIV/AIDS BALTIMORE
巴尔的摩艾滋病毒/艾滋病青少年试验网络
  • 批准号:
    6637419
  • 财政年份:
    2001
  • 资助金额:
    $ 151.22万
  • 项目类别:
Adolescent Trials Network for HIV/AIDS Interventions
青少年艾滋病毒/艾滋病干预试验网络
  • 批准号:
    7196463
  • 财政年份:
    2001
  • 资助金额:
    $ 151.22万
  • 项目类别:
Adolescent Trials Network for HIV/AIDS Interventions
青少年艾滋病毒/艾滋病干预试验网络
  • 批准号:
    7690934
  • 财政年份:
    2001
  • 资助金额:
    $ 151.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了